Recent Finacing
Recent Raise
Yumanity Therapeutics develops disease‑modifying therapies for neurodegenerative disorders (Alzheimer’s, Parkinson’s, ALS) using integrated proprietary discovery platforms, yeast‑based high‑throughput screening, and protein‑misfolding phenotype reversal.
